ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Is More Better? ASCO Plenary Session Opens Debate On High-Dose Chemotherapy

May 28, 1999

CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.

February 4, 2005

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

Lymphoma Foundation Offers Research Grants

June 28, 1996